The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
Open accessAbstract
Global obesity is a pandemic status, estimated to affect over 2 billion people, that has resulted in an enormous strain on healthcare systems worldwide. The situation is compounded by the fact that apart from the direct costs associated with overweight pathology, obesity presents itself with a number of comorbidities, including an increased risk for the development of neurodegenerative disorders. Alzheimer disease (AD), the main cause of senile dementia, is no exception. Spectacular failure of the pharmaceutical industry to come up with effective AD treatment strategies is forcing the broader scientific community to rethink the underlying molecular mechanisms leading to cognitive decline. To this end, the emphasis is once again placed on the experimental animal models of the disease. In the current study, we have focused on the effects of a high-fat diet (HFD) on hippocampal-dependent memory in C57/Bl6 Wild-type (WT) and APPswe/PS1dE9 (APP/PS1) mice, a well-established mouse model of familial AD. Our results indicate that the continuous HFD administration starting at the time of weaning is sufficient to produce β-amyloid-independent, hippocampal-dependent memory deficits measured by a 2-object novel-object recognition test (NOR) in mice as early as 6months of age. Furthermore, the resulting metabolic syndrome appears to have direct effects on brain insulin regulation and mitochondrial function. We have observed pathological changes related to both the proximal and distal insulin signaling pathway in the brains of HFD-fed WT and APP/PS1 mice. These changes are accompanied by a significantly reduced OXPHOS metabolism, suggesting that mitochondria play an important role in hippocampus-dependent memory formation and retention in both the HFD-treated and AD-like rodents at a relatively young age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also worth noting that insulin resistance leads to a reduced Aβ degradation by IDE, hence promoting the Aβ accumulation (Ho et al., 2004; Zhao et al., 2004; Petrov et al., 2015).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Petrov et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Flagged first, then by citations
2 of the 78 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mattson, 1997, Mother’s legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
Cited by
Sorted by citations
Items 101–162 of 162
11β-HSD1 Inhibition Rescues SAMP8 Cognitive Impairment Induced by Metabolic Stress
Puigoriol‐Illamola, D., Leiva, R., Vázquez‐Carrera, M., Vázquez, S., Griñán‐Ferré, C., & Pallàs, M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01708-4 · Cited by 16
Cross-Talk Between Obesity and Central Nervous System: Role in Cognitive Function
Sousa, R. A. L. D. (2019) · Interventions in Obesity & Diabetes · doi:10.31031/iod.2019.03.000551 · Cited by 14
“Obesity-induced neuroinflammation has shown to affect brain areas related to cognitive performance and memory, such as the hippocampus, and cortex [7,8].”
BackgroundKourti, M., & Metaxas, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106427 · Cited by 17
Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance
Zhu, C., Schwarz, P., Abakumova, I., & Aguzzi, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144983 · Cited by 13
Espinosa-Jiménez, T., Cano, A. C., Sánchez‐López, E., Olloquequi, J., Folch, J., Bulló, M., Verdaguer, E., Auladell, C., Pont, C., Muñoz‐Torrero, D., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01000-y · Cited by 13
“HFD consumption leads to metabolic alterations, including insulin resistance and T2DM [59, 60], both conditions frequently associated with the development of dementia [41, 61].”
BackgroundMethodEttcheto, M., Sánchez‐López, E., Cano, A. C., Carrasco, M., Herrera, K., Manzine, P. R., Espinosa-Jiménez, T., Busquets, O., Verdaguer, E., Olloquequi, J., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00646-w · Cited by 12
Jara-Moreno, D., Castro-Torres, R. D., Ettcheto, M., Auladell, C., Kogan, M. J., Folch, J., Verdaguer, E., Cano, A. C., Busquets, O., Delporte, C. L., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180174 · Cited by 12
Ayyadevara, S., Ganne, A., Hendrix, R. D., Balasubramaniam, M., Reis, R. J. S., & Barger, S. W. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.11.005 · Cited by 11
“In rodents, diet-induced obesity (DIO)—resulting from feeding either a high-fat or “western” diet (below)— impairs both insulin signaling and mitochondrial functions, which have been implicated in memory loss (Barnard et al., 2014; Petrov et al., 2015; Yuzefovych et al., 2013).”
BackgroundLo, C. H., & Zeng, J. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102891 · Cited by 14
Cognitive decline in diabetic mice predisposed to Alzheimer’s disease is greater than in wild type
Carús-Cadavieco, M., Berenguer, I., Canelo, A. M., Serrano-Lope, M. A., la Fuente, S. G., Aguado, B., Fernández‐Rodrigo, A., Saido, T. C., Frank, A., Venero, C., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201789 · Cited by 9
“…alterations in mitochondrial function, in oxidative stress, in inflammation, cellular proteostasis, and cellular metabolism (Studzinski et al, 2009; Morrison et al, 2010; Arnold et al, 2014; Petrov et al, 2015) that could easily explain how this metabolic alteration leads to cognitive deficits.”
BackgroundMaj, M. A., Gehani, T. R., Immoos, C. E., Medrano, M. S., Fanter, R. K., Strand, C. R., Glanz, H., Piccolo, B. D., Abo-Ismail, M. K., Frano, M. R. L., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12091193 · Cited by 9
Early-life metabolic dysfunction impairs cognition and mitochondrial function in mice
Vilela, W. R., Bellozi, P. M. Q., Picolo, V. L., Cavadas, B. N., Marques, K. V. S., Pereira, L. T. G., Guirao, A. R. D. Y., Amato, A. A., Magalhães, K. G., Mortari, M. R., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109352 · Cited by 11
Rojas, M., Novau-Ferré, N., Gutiérrez-Tordera, L., Ettcheto, M., Folch, J., Papandreou, C., Panisello, L., Cano, A. C., Mostafa, H. M. A., Mateu-Fabregat, J., et al. (2024) · Nutrients · doi:10.3390/nu16070955 · Cited by 8
“…mice fed with the HFD showed an increased body weight when compared to the mice fed with conventional chow ( p = 0.0024 for WT, p ≤ 0.0001 for APP/PS1) (Figure 1A). the deleterious e ff ect of following an HFD on AD pathology according to the genotype were previously published by our group [45–47].”
MethodInfluentialSanz-Martos, A. B., Roca, M., Plaza, A., Merino, B., Ruiz‐Gayo, M., & Olmo, N. D. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110108 · Cited by 9
“…by leptin (Fern ´ andez-Felipe et al., 2021; Valladoli-d-Acebes et al., 2013) and insulin resistance (Fu et al., 2017; Kothari et al., 2017; Petrov et al., 2015; Spinelli et al., 2017), able to trigger synaptic plasticity deficits (Grillo et al., 2015, 2019; Spinelli et al., 2017; Van…”
BackgroundBinayi, F., Zardooz, H., Ghasemi, R., Hedayati, M., Askari, S., Pouriran, R., & Sahraei, M. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113312 · Cited by 8
Rizk, F. H., Soliman, N. A., Heabah, N. A. E.-G., Ghafar, M. T. A., El-Attar, S. H., & Saadany, A. A. E. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00186 · Cited by 8
Wang, L., Liu, Y., Gao, H., Ge, S., Yao, X., Liu, C., & Tan, X. (2023) · Molecules · doi:10.3390/molecules28135132 · Cited by 7
“A HFD has been reported to induce liver mitochondrial dysfunction, including downregulating mitochondrial biogenesis, mitochondrial respiration, ATP synthesis, and mitochondrial dynamics [26,35,36].”
BackgroundGan, L., Ma, D., Li, M., Yang, F.-C., Rogers, R. S., Wheatley, J. L., Koch, L. G., Britton, S. L., Thyfault, J. P., Geiger, P. C., et al. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.009 · Cited by 7
“Metabolic syndrome and HFD have been linked to neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) [10, 11, 12].”
BackgroundMitchell, C. S., Goodman, E. K., Tedesco, C. R., Nguyen, K., Zhang, L., Herzog, H., & Begg, D. P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.841935 · Cited by 7
“The mechanisms by which HF and HFHS diets reduce MWM performance in IR mice remain unclear, however a HF diet can lead to reduced hippocampal intrinsic excitability (Underwood and Thompson, 2016) and downregulation of hippocampal insulin signaling (Petrov et al., 2015; Fu et al., 2017).”
BackgroundWang, W., Tanokashira, D., Shibayama, Y., Tsuji, R., Maruyama, M., Kuroiwa, C., Saito, T., Saido, T. C., & Taguchi, A. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12257 · Cited by 5
Plucińska, K., Mody, N., Dekeryte, R., Shearer, K., Mcilroy, G. D., Delibegović, M., & Platt, B. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1806190 · Cited by 7
“plaque load [49,50], elevated brain TNFα levels [51], heightened glial activation and decreased hippocampal neuronal densities [52] as well as deficits in contextual, episodic [53,54] and spatial memory [50,51].”
Backgroundvan Heusden, F. C., Bonsón, S. P. I., Stiedl, O., Smit, A. B., & van Kesteren, R. E. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.655449 · Cited by 5
“, 2012), novel object recognition (Guo et al., 2015; Petrov et al., 2015), and the hole-board maze (Reiserer et al.”
BackgroundDiabetes and cognitive dysfunction
Kim, B., Sims‐Robinson, C., Sakowski, S. A., & Feldman, E. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00027-7 · Cited by 8
Chen, Y., Wang, D., Liao, Y., Zuo, G., & Lu, X. (2024) · Discover Medicine · doi:10.1007/s44337-024-00135-2 · Cited by 5
Astrocytes at the intersection of ageing, obesity, and neurodegeneration
Firth, W., Pye, K. R., & Potter, P. G. W. (2024) · Clinical Science · doi:10.1042/cs20230148 · Cited by 6
“…(IRS1) and Ras/Raf/ERK signalling pathways, decreases glucose transporter presence at the cell membrane (potentially impairing glucose uptake), and reduces ERK/CREB signalling, which could all contribute to the observed impairments to long term potentiation 252 and thus advance the pathology of AD.”
Mechanisms Underlying Obesity-induced Aβ Accumulation in Alzheimer's Disease: A Qualitative Review
Wen, W., Huang, S.-M., & Zhang, B. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2309163 · Cited by 5
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease
Crook, H., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240730 · Cited by 5
“For example, when fed on a high-fat diet, APP/PS1 and PSEN1 transgenic AD mice demonstrate abnormal insulin signaling and mitochondrial homeostasis, as well as hippocampal-dependent memory impairments, independent from A (cid:2) load [14].”
Thoughts on Obesity and Brain Glucose
Heneka, M. T., & Nicotera, P. (2016) · Cell · doi:10.1016/j.cell.2016.04.057 · Cited by 5
“Nevertheless, other studies (Petrov et al., 2015) have shown that high-fat diet can elicit Aß-independent effects on hippocampal learning paradigms.”
BackgroundHuang, Y.-W., & Yun, K. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.01.165 · Cited by 5
Massaro, A., Calvi, P., Restivo, I., Giardina, M., Mulè, F., Tesoriere, L., Amato, A., Nuzzo, D., Picone, P., Terzo, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073077 · Cited by 4
“InsR levels on the cell membrane within the CNS are markedly reduced in dysmetabolism-associated neurodegenerative diseases [50].”
Microbiome and metabolism: Advancements in microbiome engineering
Mavros, C. F., & Ronda, C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100404 · Cited by 4
Wang, M., Jin, B., Xu, J., & Wang, C. (2025) · Nutrients · doi:10.3390/nu17162679 · Cited by 4
“Increasing evidence suggests that neuroinflammation may contribute to insulin resistance in the brain, thereby linking metabolic disorders to neurodegeneration [56–58].”
Busquets, O., Carrasco, M., Espinosa-Jiménez, T., Ettcheto, M., Verdaguer, E., Auladell, C., Bulló, M., Camins, A., Pinent, M., Rodríguez‐Gallego, E., et al. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1995118 · Cited by 3
Umare, M. D., Bajaj, K. K., Wankhede, N. L., Taksande, B. G., Upaganlawar, A., Umekar, M. J., & Kale, M. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00031-3 · Cited by 3
A high fat diet potentiates neonatal iron overload-induced memory impairments in rats
do Nascimento, F. V., de Freitas, B. S., dos Passos, M. P., Kleverston, L., dos Santos, C. D. S., Kist, L. W., Bogo, M. R., Bromberg, E., & Schröder, N. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03333-x · Cited by 3
“Among the findings are increased brain inflammation, poorer performance in memory tests, changes in brain glucose transporters (GLUTs) insulin regulation and mitochondrial function, and increased amyloid plaques deposition [20, 21].”
Kuili, P., Karmakar, V., Chatterjee, A., Lim, W. M., & Gorain, B. (2026) · BioNanoScience · doi:10.1007/s12668-026-02478-9 · Cited by 2
Is Fat Mass Cross-Sectionally Associated with Cortical Aβ Load in the Human Brain?
Maltais, M. L., Barreto, P. D. S., Rolland, Y., & Vellas, B. J. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1121-6 · Cited by 2
Priya, C. S., Vidhya, R., Kalivarathan, J., & Anuradha, C. V. (2020) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2020.10.2.l8-17 · Cited by 2
Asadbegi, M., Komaki, A., Amiri, P., Karimi, S. A., Yaghmaei, P., Ebrahim‐Habibi, A., & Salehi, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110416 · Cited by 2
Tissue-specific immune and MAPK signatures in models of reduced Progranulin and Western diet
Merchak, A. R., Rodrigues, M. E. D. S., Cole, C. L., Neighbarger, N. K., Bhavsar, N., Wallings, R. L., Joers, V. L., Chang, J., Kelly, S. D., Sampson, T. R., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107287 · Cited by 1
“The administration of a HFHC diet also leads to disrupted insulin signaling in the hippocampus (Petrov et al., 2015).”
A systematic review on the effects of hypercaloric diet in animal models of Alzheimer's disease
Carbone, E., Scibetta, S., Cappella, M., Crestini, A., Perrone, F., Hallulli, M., Rosa, P., Rivabene, R., Maiolo, F., Simonelli, V., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261448495 · Cited by 1
“Five studies reported poorer object recognition in HD-fed animals, 15,30,34,45,84 while four 32,56,82,96 found no signi fi cant differences.”
Chapter Six - Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
Giorgi, C., Marchi, S., Simoes, I., Ren, Z., Morciano, G., Perrone, M., Patalas‐Krawczyk, P., Borchard, S., Jędrak, P., Pierzynowska, K., et al. (2018) · UCL Discovery (University College London) · Cited by 1
Obesity as a Neurobiologic Disorder: A Heavyweight Contender
Chávez-Castillo, M., Durán, P., Garrido, B., Díaz, A., Escalona, D., & Cano, C. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220527120848 · Cited by 1
Hippocampus - More than Just Memory
Burman, D. D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106303 · Cited by 1
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Wang, Y., Jing, G., Fu, Y., Li, Y., & Wu, C. (2024) · Diseases & Research · doi:10.54457/dr.202401007 · Cited by 1
Mitochondrial Link Between Metabolic Syndrome and Pre-Alzheimer’s Disease
Apaijai, N., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2018) · InTech eBooks · doi:10.5772/intechopen.75306 · Cited by 1
“By contrast, the consumption of a HFD led to a markedly decreased brain mitochondrial biogenesis and aggravated cognitive impairment in APPswe/ PS1dE9 mice [17, 18].”
BackgroundInfluentialSánchez-Melgar, A., Izquierdo-Ramírez, P. J., Palomera‐Ávalos, V., Pallàs, M., Albasanz, J. L., & Martı́n, M. (2021) · Nutrients · doi:10.3390/nu13093040 · Cited by 1
“In the present study, we found increased A2AR levels in HFD fed C57BL/6J mice, a diet that also induces hippocampal-dependent memory deficits in C57BL/6J mice treated since their weaning until 6 months of age [69] and favors the formation of βA depositions in the DG area of the hippocampus when treated since their wea…”
BackgroundGomaa, A. A., Farghaly, H. S. M., Makboul, R. M., Hussien, A. M., & Nicola, M. A. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03765-0 · Cited by 1
RetractedRole of Mitochondria in Neurodegeneration in Obesity and Type 2 Diabetes
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00013-4
Sánchez‐Sarasúa, S. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14112.2021.368012
Estrategia de lucha contra "Ceratitis Capitata w." en cítricos
Olmos, R. V. M. (2002) · Hispana
Wang, W. J., Tanokashira, D., Maruyama, M., Kuroiwa, C., Saito, T., Saido, T. C., & Taguchi, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.21.473697
Carús-Cadavieco, M., Berenguer, I., Canelo, A. M., Serrano-Lope, M. A., de la Fuente, S. G., Fernández‐Rodrigo, A., Saido, T. C., Garcia, A., Venero, C., Esteban, J. A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1869956/v1
Harris, B. N., Yavari, M., Ramalingam, L., Mounce, P., Maldonado, K. A., Chavira, A., Thomas, S., Scoggin, S. O., Biltz, C., & Moustaïd‐Moussa, N. (2024) · Neuroendocrinology · doi:10.1159/000536586 · Cited by 1
“This mouse model begins to develop amyloid plaques and behavioral de fi cits around 4 months of age, with severity increasing with age. b The four behavioral tasks completed in this study; each mouse completed each task (References in a : 1 [47], 2 [48], 3 [44], 4 [55], 5 [49]).”
BackgroundMethodInfluentialAnimal Models and Ethics in the Testing of Drugs for Alzheimer’s Disease
Roychowdhury, P., Justin, A., Gobinath, M., Karri, V. V. S. R., & Kuppusamy, G. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_17
Ettcheto, M., Sánchez‐López, E., Cano, A., Carrasco, M., Herrera, K., Manzine, P. R., Espinosa-Jiménez, T., Busquets, O., Verdaguer, E., Olloquequi, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15040849
El-Emamed, M. M. A., Ibrahim, M. A., Qelliny, M. R., Mostafa, M., Sayed, M. M. E., Kilany, M. S., Alsemeh, A. E., Moawad, R. S., & Mansour, M. F. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10286-z
“Hyperlipidemia is not only a significant risk for ath - erosclerosis, ischemic stroke, and coronary heart disease (Alloubani et al. 2021), Still it is also intimately tied to neu - rodegenerative conditions like Alzheimer’s disease (AD) [39], Parkinson’s disease [40], and anxiety [41].”
Hughes, E. P., Barton, K., Rizvi, D., Dial, K., Wang, X. X., Myakala, K., Harris, B. T., Rebeck, G. W., & Levi, M. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02499-9
“…associated with adverse effects on brain health, including cognitive impairment, anxiety symptoms, and a heightened risk of neurodegen - erative diseases (Perez-Taboada et al. 2020; Veselov et al. 2023 ; Petrov et al. 2015; Garcia-Serrano and Duarte 2020; Gupta et al. 2022; Zeng et al. 2025 ).”
Mechanistic link of obesity to depression and cognitive decline in Alzheimer’s disease
Kusi‐Mensah, K., Jones, N., Haroon, H., Veldić, M., & Choi, D. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106979
Metadata
- Authors
- Petrov, D., Pedrós, I., Artiach, G., Sureda, F. X., Barroso, E., Pallàs, M., Casadesús, G., Beas-Zarate, C., Carro, E., Ferrer, I., Vazquez-Carrera, M., Folch, J., & Camins, A.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Kent State University (US)
- Research Institute Hospital 12 de Octubre (ES)
- Corresponding author
- Camins, Antoni
- ORCID
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1852
- Issue
- 9
- Pages
- 1687-1699
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W256530927
- Cited by
- 163
- References
- 78
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 15 · 2023: 14 · 2022: 14 · 2021: 19 · 2020: 17 · 2019: 14 · 2018: 24 · 2017: 10 · 2016: 22 · 2015: 3
- FWCI
- 14.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat de Catalunya (2009/SGR00853)
- Spanish Ministerio de Ciencia e Innovación (SAF2011-23631, SAF2012-39852-C02-01, SAF2012-30708)
- CONACYT (Mexico) (0177594)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- high-fat diet, Alzheimer's disease, hippocampus, insulin signaling, mitochondrial homeostasis, metabolic syndrome, obesity, APP/PS1 mice, novel object recognition, hippocampal-dependent memory, oxidative phosphorylation, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
